Why Vitamin Shoppe (VSI) Spiked on Tuesday

NEW YORK (TheStreet) -- Vitamin Shoppe (VSI) spiked on Tuesday on fourth-quarter earnings and sales which came in better than expected.

By market close, shares had added 8% to $45.33.

Trading volume of 4 million was more than five times its three-month daily average.

The health foods chain reported net income of 38 cents a share for the three months to December. Analysts surveyed by Thomson Reuters had anticipated net income of 37 cents a share.

Quarterly revenue of $256.4 million was 15.6% higher than a year earlier and beat consensus by $3.1 million. Comparable retail store sales jumped 4.6% and e-commerce sales soared 25.5% compared to the year-ago quarter.

Also See: GNC Holdings Plummets on Weak 2014 Guidance

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates VITAMIN SHOPPE INC as a Buy with a ratings score of B. The team has this to say about their recommendation:

"We rate VITAMIN SHOPPE INC (VSI) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. Among the primary strengths of the company is its revenue growth. We feel these strengths outweigh the fact that the company has had sub par growth in net income."

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again